28 Chinese Companies Face FDA Automatic Detention in May 2025
Since May 2025, the U.S. FDA has placed products from 28 Chinese companies under automatic detention due to various compliance issues. Products include canned abalone, sweet potato snacks, plum-based goods, and plant-based creamers. Key reasons cited include labeling errors, pesticide residues, and unapproved additives.
Highlighted cases:
- Process control issues: Putian Huifeng’s canned abalone.
- Labeling errors: Products from companies in Shanghai, Guangdong, and Hong Kong.
- Sweeteners: Several items, including radish snacks and peanuts, were flagged for cyclamate.
- Prohibited substances: Rhodamine B and carbendazim were detected in some goods.
The most recent case involved Sichuan Maoge Food Development, whose diverse products were rejected for refusing an FDA inspection.
Under automatic detention, affected shipments can only be cleared after third-party lab testing and FDA approval. This process highlights the importance of strict compliance with U.S. import regulations to avoid delays and financial losses.
Looking for chemical products? Let suppliers reach out to you!
2026-07-13
-
Functional Ingredients Industry Overview
Collection of Markets for Functional Ingredients in Food & Nutrition and Cosmetics.Published in: Mar. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EPA Reviews Bayer’s New Fungicide Fluoxapiprolin for US Crops Disease Control Expanded Risk Assessed as Low
-
Cambodia Exports 7.8 Million Tons of Farm Produce Air-Shipped Durian Gains Fast Access to China Revenue Hits $2.87 Billion
-
Ecuador Shrimp Exports to US Face 15 Percent Tariff $170 Million Extra Cost Threatens 300000 Jobs
-
Brazil Launches EficazControl Biocontrol Agent Yields Up 3.71 Bags per Hectare Approved for Soybean Corn Disease Protection
-
Global Food Policy Shift 60-Day Rice Import Ban in Philippines EU Issues 5 Recalls on Chinese Exports in One Week
-
New Titanium Dioxide Alternative Moves Closer to Market
-
FDA Reopens the Raw Manure Debate
-
FDA and NIH Launch a New Nutrition Science Partnership
-
FDA Sharpens the Dietary Supplement Ingredient Debate
-
Trump Hits Brazilian Beef with 50 Percent Tariff Experts Warn of Price Shifts and Global Trade Shakeup
Recommend Reading
-
Australia New Zealand Approve GM Enzyme Stevia Sweetener From China for Food Use
-
Lula’s Disapproval Hits 2024 Low at 51 Percent Support Surges Among Poor and Women After US Tariff Dispute
-
EFSA Publishes Peer Review on Fungicide Prothioconazole
-
EFSA Deems Extended Use of Bacillolysin Enzyme Safe
-
EU Proposes Approval of Triacylglycerol Lipase as Food Additive
-
Covestro Unveils TPU Application Development Hub in Guangzhou, Strengthening Regional Innovation Network
-
Novo Nordisk Reports Theft of Six Drug Batches in India Authorities Warn of Severe Patient Safety Risks
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
November Refinery Petroleum Coke Market Trends Decline
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns